Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Total Non-Current Liabilities (2016 - 2025)

Altimmune (ALT) has disclosed Total Non-Current Liabilities for 16 consecutive years, with $49.3 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 824.65% to $49.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $49.3 million through Dec 2025, up 824.65% year-over-year, with the annual reading at $49.3 million for FY2025, 824.65% up from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $49.3 million at Altimmune, up from $27.1 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $49.3 million in Q4 2025, with the low at $4.1 million in Q1 2024.
  • Average Total Non-Current Liabilities over 5 years is $14.3 million, with a median of $11.1 million recorded in 2021.
  • The sharpest move saw Total Non-Current Liabilities crashed 66.41% in 2022, then surged 824.65% in 2025.
  • Over 5 years, Total Non-Current Liabilities stood at $13.6 million in 2021, then tumbled by 66.41% to $4.6 million in 2022, then fell by 3.99% to $4.4 million in 2023, then grew by 21.19% to $5.3 million in 2024, then soared by 824.65% to $49.3 million in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $49.3 million, $27.1 million, and $23.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.